Loading…

Perioperative Serum Brain Natriuretic Peptide and Cardiac Troponin in Elective Intracranial Surgery

Background There are some intracranial insults which are associated with cardiac abnormalities. Studies of these abnormalities have never been carried out in elective intracranial neurosurgery for the removal of brain tumors. Our prospective study aims at quantifying serum cardiac troponin T (cTnT)...

Full description

Saved in:
Bibliographic Details
Published in:Neurocritical care 2012-12, Vol.17 (3), p.395-400
Main Authors: Ruggieri, Francesco, Gemma, Marco, Calvi, Maria Rosa, Nicelli, Elisa, Agarossi, Andrea, Beretta, Luigi
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background There are some intracranial insults which are associated with cardiac abnormalities. Studies of these abnormalities have never been carried out in elective intracranial neurosurgery for the removal of brain tumors. Our prospective study aims at quantifying serum cardiac troponin T (cTnT) and N-terminal pro-brain natriuretic peptide (NT-proBNP) before and after elective intracranial neurosurgery for tumor resection in patients with no history of cardiac abnormality. Methods Pre- and postoperative serum cTnT and NT-proBNP were measured in 108 patients submitted to elective major intracranial surgery for the removal of neoplastic lesions. We tested potentially predictive models for these biomarker serum levels. Results cTnT was undetectable both before and after surgery. Median (IQR) basal NT-proBNP was 35 (18–69) pg/mL and 110 (51–191) pg/mL after surgery. In a multiple linear regression model, basal NT-proBNP was predicted by age, gender, BMI, and the presence of “mass effect” (midline shift or effaced perimesencephalic cisterns on preoperative CT scan) (whole model P  
ISSN:1541-6933
1556-0961
DOI:10.1007/s12028-012-9684-2